Healthcare | March 23, 2023
OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Time to combine innovation, access and technology to deliver positive patient outcomes
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Subscribe To Our Newsletter & Stay Updated
